speb/financial-data huggingface dataset:
DBD balance_sheet (annual, 2023-12-31) — Current Debt: 300000.00
DBD balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 39900000.00
DBD balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 376200000.00
DBD balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 376200000.00
DBD balance_sheet (annual, 2023-12-31) — Current Liabilities: 1421000000.00
DBD income_statement (annual, 2023-12-31) — Diluted Average Shares: 37566678.00
DBD balance_sheet (annual, 2023-12-31) — Employee Benefits: 112600000.00
DBD balance_sheet (annual, 2023-12-31) — Finished Goods: 242000000.00
DBD balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 7600000.00
DBD balance_sheet (annual, 2023-12-31) — Goodwill: 612300000.00
DBD balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 1503600000.00
DBD balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 725400000.00
DBD balance_sheet (annual, 2023-12-31) — Gross PPE: 272000000.00
DBD balance_sheet (annual, 2023-12-31) — Inventory: 589800000.00
DBD balance_sheet (annual, 2023-12-31) — Invested Capital: 2316500000.00
DBD balance_sheet (annual, 2023-12-31) — Investments And Advances: 6500000.00
DBD balance_sheet (annual, 2023-12-31) — Land And Improvements: 21600000.00
DBD balance_sheet (annual, 2023-12-31) — Leases: 6600000.00
DBD balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 65100000.00
DBD balance_sheet (annual, 2023-12-31) — Long Term Debt: 1252400000.00
DBD balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1317500000.00
DBD balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 76000000.00
DBD balance_sheet (annual, 2023-12-31) — Minority Interest: 15400000.00
DBD balance_sheet (annual, 2023-12-31) — Net Debt: 702500000.00
DBD balance_sheet (annual, 2023-12-31) — Net PPE: 257700000.00
DBD balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -439800000.00
DBD balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 71400000.00
DBD balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 204900000.00
DBD balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 71400000.00
DBD balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 204900000.00
DBD balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 112600000.00
DBD balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 37566678.00
DBD balance_sheet (annual, 2023-12-31) — Other Current Assets: 192600000.00
DBD balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 300000.00
DBD balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 315800000.00
DBD balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 7600000.00
DBD balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 891300000.00
DBD balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 168900000.00
DBD balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 26800000.00
DBD balance_sheet (annual, 2023-12-31) — Other Properties: 110400000.00
DBD balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 13400000.00
DBD balance_sheet (annual, 2023-12-31) — Payables: 529000000.00
DBD balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 689100000.00
DBD balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
DBD balance_sheet (annual, 2023-12-31) — Prepaid Assets: 44000000.00
DBD balance_sheet (annual, 2023-12-31) — Properties: 0.00
DBD balance_sheet (annual, 2023-12-31) — Raw Materials: 347800000.00
DBD balance_sheet (annual, 2023-12-31) — Receivables: 721800000.00
DBD balance_sheet (annual, 2023-12-31) — Restricted Cash: 42100000.00
DBD balance_sheet (annual, 2023-12-31) — Retained Earnings: 17100000.00
DBD balance_sheet (annual, 2023-12-31) — Share Issued: 37566678.00
DBD balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1063800000.00
DBD balance_sheet (annual, 2023-12-31) — Tangible Book Value: -439800000.00
DBD balance_sheet (annual, 2023-12-31) — Total Assets: 4162000000.00
DBD balance_sheet (annual, 2023-12-31) — Total Capitalization: 2316200000.00
DBD balance_sheet (annual, 2023-12-31) — Total Debt: 1357400000.00
DBD balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1079200000.00
DBD balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 3082800000.00
DBD balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 2008100000.00
DBD balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1661800000.00
DBD balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
DBD balance_sheet (annual, 2023-12-31) — Treasury Stock: 0.00
DBD balance_sheet (annual, 2023-12-31) — Working Capital: 732900000.00
DBD cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 1600000.00
DBD balance_sheet (quarterly, 2024-09-30) — Current Debt: 800000.00
DBD balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 800000.00
DBD balance_sheet (quarterly, 2024-09-30) — Current Notes Payable: 800000.00
DBD income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: -600000.00
DBD balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 6700000.00
DBD cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 100000.00
DBD cash_flow (quarterly, 2024-09-30) — Other Cash Adjustment Outside Changein Cash: 0.00
DBD balance_sheet (quarterly, 2024-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 171100000.00
DBD income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
DBD income_statement (quarterly, 2024-09-30) — Special Income Charges: -2200000.00
DBD income_statement (quarterly, 2024-09-30) — Write Off: 1600000.00
DBD income_statement (annual, 2024-12-31) — +Operating Expense: 737200000.00
DBD income_statement (annual, 2024-12-31) — +Total Revenue: 3751100000.00
DBD balance_sheet (annual, 2024-12-31) — Accounts Payable: 460200000.00
DBD balance_sheet (annual, 2024-12-31) — Accounts Receivable: 588500000.00
DBD balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -41800000.00
DBD balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1048400000.00
DBD balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -10900000.00
DBD cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 92200000.00
DBD cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: 23900000.00
DBD cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 92200000.00
DBD cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: 23900000.00
DBD cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 1900000.00
DBD cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 300000.00
DBD balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 9600000.00
DBD balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 9600000.00
DBD income_statement (annual, 2024-12-31) — Basic Average Shares: 37600000.00
DBD income_statement (annual, 2024-12-31) — Basic EPS: -0.44
DBD cash_flow (annual, 2024-12-31) — Beginning Cash Position: 592300000.00
DBD balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 47300000.00
DBD balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 47300000.00
DBD cash_flow (annual, 2024-12-31) — Capital Expenditure: -40400000.00
DBD cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -40400000.00
DBD balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 119600000.00
DBD balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 119600000.00
DBD balance_sheet (annual, 2024-12-31) — Capital Stock: 400000.00
DBD balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 296200000.00
DBD balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 313100000.00
DBD cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -366500000.00
DBD cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -45500000.00
DBD cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 149200000.00
DBD cash_flow (annual, 2024-12-31) — Change In Account Payable: -42200000.00
DBD cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 34800000.00
DBD cash_flow (annual, 2024-12-31) — Change In Inventory: 20900000.00
DBD cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 3000000.00
DBD cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -51000000.00
DBD cash_flow (annual, 2024-12-31) — Change In Payable: -42200000.00
DBD cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -7400000.00
DBD cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -22900000.00
DBD cash_flow (annual, 2024-12-31) — Change In Receivables: 99600000.00
DBD cash_flow (annual, 2024-12-31) — Change In Working Capital: 62100000.00
DBD cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 99600000.00
DBD cash_flow (annual, 2024-12-31) — Changes In Cash: -262800000.00
DBD balance_sheet (annual, 2024-12-31) — Common Stock: 400000.00
DBD balance_sheet (annual, 2024-12-31) — Common Stock Equity: 929800000.00
DBD cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
DBD balance_sheet (annual, 2024-12-31) — Construction In Progress: 13500000.00
DBD balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 13500000.00
DBD income_statement (annual, 2024-12-31) — Cost Of Revenue: 2831100000.00
DBD balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 173200000.00
DBD balance_sheet (annual, 2024-12-31) — Current Assets: 1667900000.00
DBD balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 43300000.00
DBD balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 43300000.00
DBD balance_sheet (annual, 2024-12-31) — Current Debt: 200000.00
DBD balance_sheet (quarterly, 2024-12-31) — Current Debt: 200000.00
DBD balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 43500000.00
DBD balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 43500000.00
DBD balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 320700000.00
DBD balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 320700000.00
DBD balance_sheet (annual, 2024-12-31) — Current Liabilities: 1266300000.00
DBD cash_flow (annual, 2024-12-31) — Deferred Income Tax: -34100000.00
DBD cash_flow (annual, 2024-12-31) — Deferred Tax: -34100000.00
DBD cash_flow (annual, 2024-12-31) — Depreciation: 132300000.00
DBD cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 132300000.00
DBD cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 132300000.00
DBD income_statement (annual, 2024-12-31) — Diluted Average Shares: 37600000.00
DBD income_statement (annual, 2024-12-31) — Diluted EPS: -0.44
DBD income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -16500000.00
DBD income_statement (annual, 2024-12-31) — EBIT: 202600000.00
DBD income_statement (annual, 2024-12-31) — EBITDA: 334900000.00
DBD income_statement (annual, 2024-12-31) — Earnings From Equity Interest Net Of Tax: 2500000.00
DBD cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -18200000.00
DBD balance_sheet (annual, 2024-12-31) — Employee Benefits: 124400000.00
DBD cash_flow (annual, 2024-12-31) — End Cash Position: 311300000.00
DBD cash_flow (annual, 2024-12-31) — Financing Cash Flow: -366500000.00
DBD balance_sheet (annual, 2024-12-31) — Finished Goods: 183900000.00
DBD cash_flow (annual, 2024-12-31) — Free Cash Flow: 108800000.00
DBD income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 13800000.00
DBD balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -117900000.00
DBD balance_sheet (annual, 2024-12-31) — Goodwill: 586400000.00
DBD balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1365000000.00
DBD balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 599400000.00
DBD balance_sheet (annual, 2024-12-31) — Gross PPE: 288000000.00
DBD income_statement (annual, 2024-12-31) — Gross Profit: 920000000.00
DBD cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 56100000.00
DBD income_statement (annual, 2024-12-31) — Interest Expense: 155300000.00
DBD income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 155300000.00
DBD income_statement (annual, 2024-12-31) — Interest Income: 12300000.00
DBD income_statement (annual, 2024-12-31) — Interest Income Non Operating: 12300000.00
DBD cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 149400000.00
DBD balance_sheet (annual, 2024-12-31) — Inventory: 528100000.00
DBD balance_sheet (annual, 2024-12-31) — Invested Capital: 1857100000.00
DBD cash_flow (annual, 2024-12-31) — Investing Cash Flow: -45500000.00
DBD balance_sheet (annual, 2024-12-31) — Investments And Advances: 7000000.00
DBD balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 7000000.00
DBD cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1220400000.00
DBD cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 1181100000.00
DBD balance_sheet (annual, 2024-12-31) — Land And Improvements: 17200000.00
DBD balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 17200000.00
DBD balance_sheet (annual, 2024-12-31) — Leases: 3500000.00
DBD balance_sheet (quarterly, 2024-12-31) — Leases: 3500000.00
DBD balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 76300000.00
DBD balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 76300000.00
DBD balance_sheet (annual, 2024-12-31) — Long Term Debt: 927300000.00
DBD balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 927300000.00
DBD cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1220400000.00
DBD cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 1181100000.00
DBD cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -1520500000.00
DBD cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -1320400000.00
DBD balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 66500000.00
DBD balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 66500000.00
DBD balance_sheet (annual, 2024-12-31) — Minority Interest: 8400000.00
DBD income_statement (annual, 2024-12-31) — Minority Interests: -2000000.00
DBD cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
DBD cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
DBD balance_sheet (annual, 2024-12-31) — Net Debt: 631100000.00
DBD cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -23500000.00
DBD income_statement (annual, 2024-12-31) — Net Income: -16500000.00
DBD income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -16500000.00
DBD income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -14500000.00
DBD income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -16500000.00
DBD income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -16500000.00
DBD cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -14500000.00
DBD income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -14500000.00
DBD income_statement (annual, 2024-12-31) — Net Interest Income: -143000000.00
DBD cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -6400000.00
DBD cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -300100000.00
DBD cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -139300000.00
DBD cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -300100000.00
DBD cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -139300000.00
DBD income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -143000000.00
DBD cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -66400000.00
DBD cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 1300000.00
DBD cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
DBD balance_sheet (annual, 2024-12-31) — Net PPE: 246200000.00
DBD balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -435200000.00
DBD balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 69500000.00
DBD balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 176800000.00
DBD balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 69500000.00
DBD balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 176800000.00
DBD balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 124400000.00
DBD income_statement (annual, 2024-12-31) — Normalized EBITDA: 328900000.00
DBD income_statement (annual, 2024-12-31) — Normalized Income: -21240000.00
DBD cash_flow (annual, 2024-12-31) — Operating Cash Flow: 149200000.00
DBD cash_flow (annual, 2024-12-31) — Operating Gains Losses: -23500000.00
DBD income_statement (annual, 2024-12-31) — Operating Income: 182800000.00
DBD income_statement (annual, 2024-12-31) — Operating Revenue: 3751100000.00
DBD balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 37576678.00
DBD cash_flow (annual, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: 0.00
DBD cash_flow (quarterly, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: 0.00
DBD balance_sheet (annual, 2024-12-31) — Other Current Assets: 177300000.00
DBD balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 200000.00
DBD balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 200000.00
DBD balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 312200000.00
DBD balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -117900000.00
DBD income_statement (annual, 2024-12-31) — Other Income Expense: 7500000.00
DBD balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 778600000.00
DBD cash_flow (annual, 2024-12-31) — Other Non Cash Items: 17200000.00
DBD balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 194900000.00
DBD balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 110500000.00
DBD income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 1500000.00
DBD balance_sheet (annual, 2024-12-31) — Other Properties: 140000000.00
DBD balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 16900000.00
DBD income_statement (annual, 2024-12-31) — Other Special Charges: 7100000.00
DBD balance_sheet (annual, 2024-12-31) — Payables: 460200000.00
DBD balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 633400000.00
DBD cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: 4400000.00
DBD balance_sheet (annual, 2024-12-31) — Prepaid Assets: 45800000.00
DBD income_statement (annual, 2024-12-31) — Pretax Income: 47300000.00
DBD balance_sheet (annual, 2024-12-31) — Properties: 0.00
DBD balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
DBD cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
DBD cash_flow (annual, 2024-12-31) — Purchase Of Investment: -295200000.00
DBD balance_sheet (annual, 2024-12-31) — Raw Materials: 344200000.00
DBD balance_sheet (annual, 2024-12-31) — Receivables: 588500000.00
DBD income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 2831100000.00
DBD income_statement (annual, 2024-12-31) — Reconciled Depreciation: 132300000.00
DBD cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1520500000.00
DBD cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -1320400000.00
DBD cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
DBD income_statement (annual, 2024-12-31) — Research And Development: 93600000.00
DBD balance_sheet (annual, 2024-12-31) — Restricted Cash: 15100000.00
DBD balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 15100000.00
DBD income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
DBD income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
DBD balance_sheet (annual, 2024-12-31) — Retained Earnings: -1100000.00
DBD cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
DBD cash_flow (annual, 2024-12-31) — Sale Of Investment: 288800000.00
DBD income_statement (annual, 2024-12-31) — Selling General And Administration: 643600000.00
DBD balance_sheet (annual, 2024-12-31) — Share Issued: 37576678.00
DBD income_statement (annual, 2024-12-31) — Special Income Charges: -7800000.00
DBD income_statement (quarterly, 2024-12-31) — Special Income Charges: -8400000.00
DBD cash_flow (annual, 2024-12-31) — Stock Based Compensation: 9700000.00
DBD balance_sheet (annual, 2024-12-31) — Stockholders Equity: 929800000.00
DBD balance_sheet (annual, 2024-12-31) — Tangible Book Value: -435200000.00
DBD income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 1260000.00
DBD income_statement (annual, 2024-12-31) — Tax Provision: 64300000.00
DBD income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
DBD balance_sheet (annual, 2024-12-31) — Total Assets: 3543500000.00
DBD balance_sheet (annual, 2024-12-31) — Total Capitalization: 1857100000.00
DBD balance_sheet (annual, 2024-12-31) — Total Debt: 927300000.00
DBD balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 938200000.00
DBD income_statement (annual, 2024-12-31) — Total Expenses: 3568300000.00
DBD balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2605300000.00
DBD balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1875600000.00
DBD balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1339000000.00
DBD income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 182100000.00
DBD income_statement (annual, 2024-12-31) — Total Unusual Items: 6000000.00
DBD income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 6000000.00
DBD balance_sheet (annual, 2024-12-31) — Treasury Stock: 0.00
DBD balance_sheet (annual, 2024-12-31) — Working Capital: 401600000.00
DBD income_statement (annual, 2024-12-31) — Write Off: 700000.00
DBD income_statement (quarterly, 2024-12-31) — Write Off: -900000.00
DBD income_statement (quarterly, 2025-03-31) — +Operating Expense: 166000000.00
DBD income_statement (quarterly, 2025-03-31) — +Total Revenue: 841100000.00
DBD balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 449500000.00
DBD balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 602600000.00
DBD balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -51300000.00
DBD balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1051400000.00
DBD balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -11000000.00
DBD cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 25400000.00
DBD cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 25400000.00
DBD balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 5600000.00
DBD income_statement (quarterly, 2025-03-31) — Basic Average Shares: 37600000.00
DBD income_statement (quarterly, 2025-03-31) — Basic EPS: -0.22
DBD cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 311300000.00
DBD cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -9600000.00
DBD cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -9600000.00
DBD balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 126400000.00
DBD balance_sheet (quarterly, 2025-03-31) — Capital Stock: 400000.00
DBD balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 306500000.00
DBD balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 314600000.00
DBD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -12800000.00
DBD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
DBD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 15700000.00
DBD cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -23500000.00
DBD cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -26000000.00
DBD cash_flow (quarterly, 2025-03-31) — Change In Inventory: -4800000.00
DBD cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 24800000.00
DBD cash_flow (quarterly, 2025-03-31) — Change In Payable: -23500000.00
DBD cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -49500000.00
DBD cash_flow (quarterly, 2025-03-31) — Change In Receivables: 400000.00
DBD cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -29100000.00
DBD cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 400000.00
DBD cash_flow (quarterly, 2025-03-31) — Changes In Cash: 2900000.00
DBD balance_sheet (quarterly, 2025-03-31) — Common Stock: 400000.00
DBD balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 984000000.00
DBD cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -9600000.00
DBD income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 638700000.00
DBD balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 149900000.00
DBD balance_sheet (quarterly, 2025-03-31) — Current Assets: 1727200000.00
DBD balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 47300000.00
DBD balance_sheet (quarterly, 2025-03-31) — Current Debt: 30000.00
DBD balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 47330000.00
DBD balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 385000000.00
DBD balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 385000000.00
DBD balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1283500000.00
DBD cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -2000000.00
DBD cash_flow (quarterly, 2025-03-31) — Deferred Tax: -2000000.00
DBD cash_flow (quarterly, 2025-03-31) — Depreciation: 8500000.00
DBD cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 33900000.00
DBD cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 33900000.00
DBD income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 37600000.00
DBD income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.22
DBD income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -8300000.00
DBD income_statement (quarterly, 2025-03-31) — EBIT: 14100000.00
DBD income_statement (quarterly, 2025-03-31) — EBITDA: 48000000.00
DBD income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest Net Of Tax: -2300000.00
DBD cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 6000000.00
DBD balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 128100000.00
DBD cash_flow (quarterly, 2025-03-31) — End Cash Position: 320200000.00
DBD cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -12800000.00
DBD balance_sheet (quarterly, 2025-03-31) — Finished Goods: 194600000.00
DBD cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 6100000.00
DBD income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -18500000.00
DBD balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -48800000.00
DBD balance_sheet (quarterly, 2025-03-31) — Goodwill: 603900000.00
DBD balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1387900000.00
DBD balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 613600000.00
DBD balance_sheet (quarterly, 2025-03-31) — Gross PPE: 306700000.00
DBD income_statement (quarterly, 2025-03-31) — Gross Profit: 202400000.00
DBD cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 6700000.00
DBD income_statement (quarterly, 2025-03-31) — Interest Expense: 21500000.00
DBD income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 21500000.00
DBD income_statement (quarterly, 2025-03-31) — Interest Income: 1500000.00
DBD income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 1500000.00
DBD cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 21400000.00
DBD balance_sheet (quarterly, 2025-03-31) — Inventory: 553000000.00
DBD balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1912730000.00
DBD cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
DBD balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 6600000.00
DBD cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
DBD balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 79100000.00
DBD balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 928700000.00
DBD balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1007800000.00
DBD cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
DBD cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
DBD balance_sheet (quarterly, 2025-03-31) — Minority Interest: 7000000.00
DBD income_statement (quarterly, 2025-03-31) — Minority Interests: -800000.00
DBD cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -9600000.00
DBD balance_sheet (quarterly, 2025-03-31) — Net Debt: 622230000.00
DBD cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 17300000.00
DBD income_statement (quarterly, 2025-03-31) — Net Income: -8300000.00
DBD income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -8300000.00
DBD income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -7500000.00
DBD income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -8300000.00
DBD income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -8300000.00
DBD cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -7500000.00
DBD income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -7500000.00
DBD income_statement (quarterly, 2025-03-31) — Net Interest Income: -20000000.00
DBD cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 9600000.00
DBD cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
DBD cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
DBD income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -20000000.00
DBD cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -3200000.00
DBD balance_sheet (quarterly, 2025-03-31) — Net PPE: 255400000.00
DBD balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -403900000.00
DBD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 70100000.00
DBD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 179800000.00
DBD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 70100000.00
DBD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 179800000.00
DBD balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 128100000.00
DBD income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 73400000.00
DBD income_statement (quarterly, 2025-03-31) — Normalized Income: 9556200.00
DBD cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 15700000.00
DBD cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 17300000.00
DBD income_statement (quarterly, 2025-03-31) — Operating Income: 36400000.00
DBD income_statement (quarterly, 2025-03-31) — Operating Revenue: 841100000.00
DBD balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 37463960.00
DBD balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 194800000.00
DBD balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 30000.00
DBD balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 251770000.00
DBD balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -48800000.00
DBD income_statement (quarterly, 2025-03-31) — Other Income Expense: -23900000.00
DBD balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 784000000.00
DBD cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 100000.00
DBD balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 178400000.00
DBD balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 35400000.00
DBD income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1500000.00
DBD income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -1700000.00
DBD balance_sheet (quarterly, 2025-03-31) — Other Properties: 306700000.00
DBD balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 8100000.00
DBD balance_sheet (quarterly, 2025-03-31) — Payables: 449500000.00
DBD balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 599400000.00
DBD balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 42900000.00
DBD income_statement (quarterly, 2025-03-31) — Pretax Income: -7400000.00
DBD cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -70900000.00
DBD balance_sheet (quarterly, 2025-03-31) — Raw Materials: 358400000.00
DBD balance_sheet (quarterly, 2025-03-31) — Receivables: 602600000.00
DBD income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 638700000.00
DBD income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 33900000.00
DBD cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
DBD cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -9600000.00
DBD income_statement (quarterly, 2025-03-31) — Research And Development: 22700000.00
DBD balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 13700000.00
DBD income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 6900000.00
DBD balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -9400000.00
DBD cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 80500000.00
DBD income_statement (quarterly, 2025-03-31) — Selling General And Administration: 145000000.00
DBD balance_sheet (quarterly, 2025-03-31) — Share Issued: 37682517.00
DBD income_statement (quarterly, 2025-03-31) — Special Income Charges: -6900000.00
DBD cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 3000000.00
DBD balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 984000000.00
DBD balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -403900000.00
DBD income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -7543800.00
DBD income_statement (quarterly, 2025-03-31) — Tax Provision: -2200000.00
DBD income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
DBD balance_sheet (quarterly, 2025-03-31) — Total Assets: 3625600000.00
DBD balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1912700000.00
DBD balance_sheet (quarterly, 2025-03-31) — Total Debt: 1055130000.00
DBD balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 991000000.00
DBD income_statement (quarterly, 2025-03-31) — Total Expenses: 804700000.00
DBD balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2634600000.00
DBD balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1898400000.00
DBD balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1351100000.00
DBD income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 29600000.00
DBD income_statement (quarterly, 2025-03-31) — Total Unusual Items: -25400000.00
DBD income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -25400000.00
DBD balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 218557.00
DBD balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 9600000.00
DBD balance_sheet (quarterly, 2025-03-31) — Working Capital: 443700000.00
DBD income_statement (quarterly, 2025-06-30) — +Operating Expense: 171500000.00
DBD income_statement (quarterly, 2025-06-30) — +Total Revenue: 915200000.00
DBD balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 431300000.00
DBD balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 599400000.00
DBD balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -60700000.00
DBD balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1054700000.00
DBD balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -10400000.00
DBD cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 22200000.00
DBD cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 22200000.00
DBD balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 6000000.00
DBD income_statement (quarterly, 2025-06-30) — Basic Average Shares: 37200000.00
DBD income_statement (quarterly, 2025-06-30) — Basic EPS: 0.33
DBD cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 320200000.00
DBD cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -17400000.00
DBD cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -17400000.00
DBD balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 131900000.00
DBD balance_sheet (quarterly, 2025-06-30) — Capital Stock: 400000.00
DBD balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 279200000.00
DBD balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 294400000.00
DBD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -31300000.00
DBD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -32800000.00
DBD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 30100000.00
DBD cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -43200000.00
DBD cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 9200000.00
DBD cash_flow (quarterly, 2025-06-30) — Change In Inventory: 9800000.00
DBD cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -46300000.00
DBD cash_flow (quarterly, 2025-06-30) — Change In Payable: -43200000.00
DBD cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -34000000.00
DBD cash_flow (quarterly, 2025-06-30) — Change In Receivables: 33000000.00
DBD cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -37500000.00
DBD cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 33000000.00
DBD cash_flow (quarterly, 2025-06-30) — Changes In Cash: -34000000.00
DBD balance_sheet (quarterly, 2025-06-30) — Common Stock: 400000.00
DBD balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1097200000.00
DBD cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -30100000.00
DBD income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 681200000.00
DBD balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 164600000.00
DBD balance_sheet (quarterly, 2025-06-30) — Current Assets: 1736500000.00
DBD balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 48700000.00
DBD balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 48700000.00
DBD balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 346700000.00
DBD balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 346700000.00
DBD balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1273700000.00
DBD cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -6800000.00
DBD cash_flow (quarterly, 2025-06-30) — Deferred Tax: -6800000.00
DBD cash_flow (quarterly, 2025-06-30) — Depreciation: 9100000.00
DBD cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 31200000.00
DBD cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 31200000.00
DBD income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 37500000.00
DBD income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.33
DBD income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 12200000.00
DBD income_statement (quarterly, 2025-06-30) — EBIT: 39000000.00
DBD income_statement (quarterly, 2025-06-30) — EBITDA: 70200000.00
DBD income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest Net Of Tax: 300000.00
DBD cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 9000000.00
DBD balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 127700000.00
DBD cash_flow (quarterly, 2025-06-30) — End Cash Position: 295200000.00
DBD cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -31300000.00
DBD balance_sheet (quarterly, 2025-06-30) — Finished Goods: 196500000.00
DBD cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 12700000.00
DBD income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -22200000.00
DBD balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 79000000.00
DBD balance_sheet (quarterly, 2025-06-30) — Goodwill: 641200000.00
DBD balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1456900000.00
DBD balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 609800000.00
DBD balance_sheet (quarterly, 2025-06-30) — Gross PPE: 327500000.00
DBD income_statement (quarterly, 2025-06-30) — Gross Profit: 234000000.00
DBD cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 20700000.00
DBD income_statement (quarterly, 2025-06-30) — Interest Expense: 21800000.00
DBD income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 21800000.00
DBD income_statement (quarterly, 2025-06-30) — Interest Income: 2500000.00
DBD income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 2500000.00
DBD cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 300000.00
DBD balance_sheet (quarterly, 2025-06-30) — Inventory: 574000000.00
DBD balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2028300000.00
DBD cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -32800000.00
DBD cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
DBD balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 83200000.00
DBD balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 931100000.00
DBD balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1014300000.00
DBD cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
DBD cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 0.00
DBD balance_sheet (quarterly, 2025-06-30) — Minority Interest: 7800000.00
DBD income_statement (quarterly, 2025-06-30) — Minority Interests: -500000.00
DBD cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -30100000.00
DBD balance_sheet (quarterly, 2025-06-30) — Net Debt: 651900000.00
DBD cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 24000000.00
DBD income_statement (quarterly, 2025-06-30) — Net Income: 12200000.00
DBD income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 12200000.00
DBD income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 12700000.00
DBD income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 12200000.00
DBD income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 12200000.00
DBD cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 12800000.00
DBD income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 12700000.00
DBD income_statement (quarterly, 2025-06-30) — Net Interest Income: -19300000.00
DBD cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -17200000.00
DBD cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
DBD cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
DBD income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -19300000.00
DBD cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1200000.00
DBD balance_sheet (quarterly, 2025-06-30) — Net PPE: 266800000.00
DBD balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -359700000.00
DBD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 69400000.00
DBD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 185300000.00
DBD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 69400000.00
DBD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 185300000.00
DBD balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 127700000.00
DBD income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 98700000.00
DBD income_statement (quarterly, 2025-06-30) — Normalized Income: 32748500.00
DBD cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 30100000.00
DBD cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 24000000.00
DBD income_statement (quarterly, 2025-06-30) — Operating Income: 62500000.00
DBD income_statement (quarterly, 2025-06-30) — Operating Revenue: 915200000.00
DBD balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 36859610.00
DBD balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 207800000.00
DBD balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 282400000.00
DBD balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 79000000.00
DBD income_statement (quarterly, 2025-06-30) — Other Income Expense: -26000000.00
DBD balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 815700000.00
DBD cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 3100000.00
DBD balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 210300000.00
DBD balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 33900000.00
DBD income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 2500000.00
DBD income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1200000.00
DBD balance_sheet (quarterly, 2025-06-30) — Other Properties: 327500000.00
DBD balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 15200000.00
DBD balance_sheet (quarterly, 2025-06-30) — Payables: 431300000.00
DBD balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 595900000.00
DBD balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 38900000.00
DBD income_statement (quarterly, 2025-06-30) — Pretax Income: 17200000.00
DBD cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -81200000.00
DBD balance_sheet (quarterly, 2025-06-30) — Raw Materials: 377500000.00
DBD balance_sheet (quarterly, 2025-06-30) — Receivables: 599400000.00
DBD income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 681200000.00
DBD income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 31200000.00
DBD cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
DBD cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -30100000.00
DBD income_statement (quarterly, 2025-06-30) — Research And Development: 22400000.00
DBD balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 16000000.00
DBD income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 6300000.00
DBD balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 2800000.00
DBD cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 64000000.00
DBD income_statement (quarterly, 2025-06-30) — Selling General And Administration: 147900000.00
DBD balance_sheet (quarterly, 2025-06-30) — Share Issued: 37715053.00
DBD income_statement (quarterly, 2025-06-30) — Special Income Charges: -6300000.00
DBD cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3300000.00
DBD balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1097200000.00
DBD balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -359700000.00
DBD income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -7951500.00
DBD income_statement (quarterly, 2025-06-30) — Tax Provision: 4800000.00
DBD income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.28
DBD balance_sheet (quarterly, 2025-06-30) — Total Assets: 3739900000.00
DBD balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2028300000.00
DBD balance_sheet (quarterly, 2025-06-30) — Total Debt: 1063000000.00
DBD balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1105000000.00
DBD income_statement (quarterly, 2025-06-30) — Total Expenses: 852700000.00
DBD balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2634900000.00